title: Dual Effect of Adenosine A1 Receptor Activation on Renal O2 Consumption.
abstract: The high requirement of O2 in the renal proximal tubule stems from a high rate of Na(+) transport. Adenosine A1 receptor (A1R) activation regulates Na(+) transport in this nephron segment. Thus, the effect of the acute activation and the mechanisms of A1R on the rate of O2 consumption were evaluated. The A1R-antagonist, 8-cyclopentyl-1,3-dipropylxanthine (CPX) and adenosine deaminase (ADA), which metabolize endogenous adenosine, reduced O2 consumption (40-50%). Replacing Na(+) in the buffer reversed the ADA- or CPX-mediated reduction of O2 consumption. Blocking the Na/H-exchanger activity, which decreases O2 usage per se, did not enhance the ADA- or CPX-induced inhibition of O2 consumption. These data indicate that endogenous adenosine increases O2 usage via the activation of Na(+) transport. In the presence of endogenous adenosine, A1R was further activated by the A1R-agonist N(6)-cyclopentyladenosine (CPA); CPA inhibited O2 usage (30%) and this effect also depended on Na(+) transport. Moreover, a low concentration of CPA activated O2 usage in tissue pretreated with ADA, whereas a high concentration of CPA inhibited O2 usage; both effects depended on Na(+). Protein kinase C signaling mediated the inhibitory effect of A1R, while adenylyl cyclase mediated its stimulatory effect on O2 consumption. In summary, increasing the local concentrations of adenosine can either activate or inhibit O2 consumption via A1R, and this mechanism depends on Na(+) transport. The inhibition of O2 usage by A1R activation might restore the compromised balance between energy supply and demand under pathophysiological conditions, such as renal ischemia, which results in high adenosine production.
authors.affiliation: Department of Medicine, University of Maryland School of Medicine, Maryland.|Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas.|Physiology and Pharmacology Department, Des Moines University, Iowa.
authors.forename: Victor
authors.initials: V
authors.lastname: Babich
authors.affiliation: Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas.
authors.forename: Komal
authors.initials: K
authors.lastname: Vadnagara
authors.affiliation: Department of Medicine, University of Maryland School of Medicine, Maryland.|Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas.|Physiology and Pharmacology Department, Des Moines University, Iowa.
authors.forename: Francesca
authors.initials: F
authors.lastname: Di Sole
mesh_terms: D000241:Adenosine / Q000378:metabolism*; D058907:Adenosine A1 Receptor Agonists / Q000494:pharmacology; D000262:Adenylyl Cyclases / Q000378:metabolism; D000818:Animals; D066298:In Vitro Techniques; D007672:Kidney Cortex / Q000187:drug effects / Q000378:metabolism*; D007687:Kidney Tubules, Proximal / Q000187:drug effects / Q000378:metabolism*; D007700:Kinetics; D008297:Male; D010101:Oxygen Consumption / Q000187:drug effects*; D011493:Protein Kinase C / Q000378:metabolism; D058915:Purinergic P1 Receptor Antagonists / Q000494:pharmacology; D017207:Rats, Sprague-Dawley; D043682:Receptor, Adenosine A1 / Q000187:drug effects / Q000378:metabolism*; D015398:Signal Transduction / Q000187:drug effects; D017923:Sodium-Hydrogen Exchangers / Q000378:metabolism
chemical_list: D058907:Adenosine A1 Receptor Agonists; D058915:Purinergic P1 Receptor Antagonists; D043682:Receptor, Adenosine A1; D017923:Sodium-Hydrogen Exchangers; D011493:Protein Kinase C; D000262:Adenylyl Cyclases; D000241:Adenosine